Curanex Pharmaceuticals Inc (CURX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,152 | -198 | N/A | N/A | -216 |
| Depreciation Amortization | 45 | 30 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 110 | -5 | N/A | N/A | 5 |
| Other Working Capital | -8,520 | -267 | N/A | N/A | -245 |
| Other Operating Activity | -109 | 0 | 0 | 0 | -5 |
| Operating Cash Flow | $-9,627 | $-440 | $N/A | $N/A | $-460 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,655 | N/A | N/A | N/A | 630 |
| Other Financing Activity | -347 | 400 | 0 | 0 | 0 |
| Financing Cash Flow | $15,309 | $400 | $N/A | $N/A | $630 |
| Beginning Cash Position | 149 | 149 | N/A | N/A | 74 |
| End Cash Position | 5,831 | 109 | N/A | N/A | 244 |
| Net Cash Flow | $5,682 | $-40 | $N/A | $N/A | $170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,627 | -440 | N/A | N/A | -460 |
| Free Cash Flow | -9,627 | -440 | 0 | 0 | -460 |